Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 1/20 | 0.46 |
| ▸ | PRKCG | P05129 | 1/20 | 0.46 |
| ▸ | PRKCB | P05771 | 1/20 | 0.46 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.46 |
| ▸ | PRKCA | P17252 | 1/20 | 0.46 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.46 |
| ▸ | PRKCH | P24723 | 1/20 | 0.46 |
| ▸ | PRKCI | P41743 | 1/20 | 0.46 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.46 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.46 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.46 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.46 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.46 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.46 |
| ▸ | HTR2C | P28335 | 6/20 | 0.44 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | SHMT1 | P34896 | 4/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22494622 | 0.88 | HTR2C (0.50) | PRKD3PRKCGPRKCBIL1R1PRKCA | |
| SCHEMBL24565746 | 0.80 | PRKD3 (0.47) | PRKD3PRKCGPRKCBIL1R1PRKCA | |
| SCHEMBL24565742 | 0.76 | PRKD3 (0.46) | PRKD3PRKCGPRKCBIL1R1PRKCA | |
| SCHEMBL24565737 | 0.74 | HTR2C (0.44) | PRKD3PRKCGPRKCBIL1R1PRKCA | |
| SCHEMBL24565484 | 0.74 | PRKD3 (0.41) | PRKD3PRKCGPRKCBIL1R1PRKCA | |
| SCHEMBL24565761 | 0.73 | KMT2A (0.43) | PRKD3PRKCGPRKCBIL1R1PRKCA | |
| SCHEMBL22637331 | 0.73 | HTR2C (0.46) | PRKD3PRKCGPRKCBIL1R1PRKCA | |
| SCHEMBL22494797 | 0.71 | HTR2C (0.67) | TLR7HTR2CNPC1RAB9AHPGD | |
| SCHEMBL22644745 | 0.71 | PRKD3 (0.43) | PRKD3PRKCGPRKCBIL1R1PRKCA | |
| SCHEMBL22637425 | 0.67 | HTR2C (0.51) | PRKD3PRKCGPRKCBIL1R1PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220204495-A1 | INHIBITING TRABID | Valo Health, LLC | 2022-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220204495-A1 | INHIBITING TRABID | TPO, PRKACG, NFKBIA | PRKD3 114/4885PRKCG 374/4885PRKCB 335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.